Ajanta Pharma USA Inc recalls Fenofibrate Capsules
- Recalling company
- Ajanta Pharma USA Inc
- Product
- Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
- Reason
- CGMP Deviations
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- May 28, 2026
- Reported
- Jul 1, 2026
- Distribution
- U.S. Nationwide
- Status
- Ongoing
- Quantity
- 3648 bottles
- Lot / codes
- Lot # PA02216; Exp. 12/2029
- Company location
- Bridgewater, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0611-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0611-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.